Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of GX-I7 in patients with glioblastoma

Trial Profile

A study of GX-I7 in patients with glioblastoma

Phase of Trial: Phase I

Latest Information Update: 25 May 2018

At a glance

  • Drugs GX I7 (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 May 2018 According to a Genexine media release, the US FDA has cleared Investigative New Drug (IND) application for GX-17 facilitating this trial.
    • 29 Dec 2017 New trial record
    • 25 Dec 2017 According to an I-Mab Biopharma media release, the company has planned this trial for 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top